Real-World Survival in Patients with Metastatic Melanoma after Discontinuation of Anti-PD-1 Immunotherapy for Objective Response or Adverse Effects: A Retrospective Study

Figure 1

Flow chart of patients selection. Abbreviation: PD, disease progression; CR, complete response; PR, partial response; SD, stable disease; AE, adverse event.